Caligor Coghlan Appoints Kerry Myers as Vice President of Business Development, Clinical Trial Services
Sep. 06, 2018
BASTROP, Texas--(BUSINESS WIRE)--Sep 6, 2018--Caligor Coghlan, a leading biopharmaceutical services company providing global clinical trial material management, supply solutions and expanded access program management, today announced the appointment of Kerry Myers as Vice President of business development for the company’s Clinical Trial Services.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180906005055/en/
Kerry Myers, Vice President of Business Development, Clinical Trial Services at Caligor Coghlan (Photo: Business Wire)
“We are thrilled to have Kerry join Caligor Coghlan in this important role,” said Lisa Rich-Milan, Chief Executive Officer. “With her extensive background in the healthcare industry, she will bring an informed and experienced perspective to our business development efforts, commercial strategy, and marketing efforts for the Clinical Trial Services business."
An industry veteran, Ms. Myers has more than fourteen years of experience designing, launching, marketing, and selling healthcare solutions. Prior to joining Caligor Coghlan, she spent seven years at Quest Diagnostics, most recently as the business leader for one of company’s fastest growing divisions, where she was responsible for developing the product pipeline, building the go-to-market strategy, and leading marketing and commercialization efforts. During her tenure at Quest, Ms. Myers held various roles focused on developing and driving analytics and technology solutions across multiple markets. Ms. Myers began her career in sales and marketing with Pfizer, and held positions of increasing responsibility at Esprit Pharma, Allergan, and Sunquest Information Systems.
“The clinical trials services team at Caligor Coghlan provides essential support to help advance, accelerate and safeguard trials around the world,” said Ms. Myers. “I’m proud to join an organization committed to helping clients be successful and ultimately deliver new treatments to patients in need.”
About Caligor Coghlan Caligor Coghlan provides global clinical trial material management, supply solutions and expanded access program management to the biopharmaceutical industry. The company solves complex supply chain challenges, helping to ensure clinical trials remain safe, efficient and on schedule. Services include commercial drug sourcing (comparators, standard of care therapies, rescue medicines, devices, ancillaries, etc.), secondary packaging, labelling, placebo manufacturing, blinding, returns, and destruction of clinical trial material as well as worldwide distribution (including direct-to-depot, direct-to-site and direct-to-patient capabilities). Caligor Coghlan operates facilities in Bastrop, TX and Dartford, UK and maintains a global network of depots to ensure rapid and timely delivery of clinical trial supplies and therapeutics to patients and physicians.
View source version on businesswire.com:https://www.businesswire.com/news/home/20180906005055/en/
CONTACT: AP Communications
Amy Phillips, 412-327-9499
KEYWORD: UNITED STATES NORTH AMERICA TEXAS
INDUSTRY KEYWORD: SUPPLY CHAIN MANAGEMENT HEALTH BIOTECHNOLOGY CLINICAL TRIALS MEDICAL DEVICES PHARMACEUTICAL RETAIL
SOURCE: Caligor Coghlan
Copyright Business Wire 2018.
PUB: 09/06/2018 07:00 AM/DISC: 09/06/2018 07:01 AM